Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T21:57:37.766Z.
Calculation as of: 2026-10-06T21:57:37.766Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bddae1a009f0b40e7fb659cb125a310776fd64778f9839bff19075a224db575c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$169.53M
Price/OCF Ratio
N/A
TTM Avg
32.12
3Y Avg
27.16
5Y Avg
27.16
Market Cap
$159.80M
Price/OCF Ratio
N/A
TTM Avg
78.89
3Y Avg
78.89
5Y Avg
78.89
Market Cap
$171.13M
Price/OCF Ratio
N/A
TTM Avg
357.25
3Y Avg
357.25
5Y Avg
357.25
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $165.27M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 8.97 | 14.06 | 42.13 | 40.06 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | N/A | N/A | N/A | N/A |
| Quanterix Corporation (QTRX)vs › | $162.04M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.92M | N/A | 7.42 | 7.42 | 7.42 |
| Journey Medical Corporation (DERM)vs › | $169.53M | N/A | 32.12 | 27.16 | 27.16 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | N/A | 78.89 | 78.89 | 78.89 |
| PepGen Inc. (PEPG)vs › | $159.78M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 357.25 | 357.25 | 357.25 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | 109.43 | 140.00 | 140.00 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
